Back to Search
Start Over
Sanofi, GSK kick-start phase 3 COVID-19 vax test as the pair targets variants, Q4 approval.
- Source :
- FierceBiotech; 5/27/2021, pN.PAG-N.PAG, 1p
- Publication Year :
- 2021
-
Abstract
- Just two weeks after seeing a positive data readout from a small midstage test, Sanofi and GlaxoSmithKline got the signoff for a much bigger phase 3, which could lead to a full approval by the fourth quarter. [ABSTRACT FROM AUTHOR]
- Subjects :
- COVID-19 testing
COVID-19
Subjects
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 150554681